Israel Englander’s Amneal Pharmaceuticals AMRX Stock Holding History

Israel Englander’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-50,000	Closed	-$622K	–	5822
2026 Q1	$622K	Buy	+50,000	New	+$671K	﹤0.01%	4659
2025 Q1	–	Sell	-250,000	Closed	-$1.98M	–	5812
2024 Q4	$1.98M	Buy	+250,000	New	+$2.1M	﹤0.01%	3653
2024 Q3	–	Sell	-150,000	Closed	-$953K	–	6063
2024 Q2	$953K	Sell	150,000 -50,000	-25%	-$317K	﹤0.01%	4142
2024 Q1	$1.21M	Buy	+200,000	New	+$1.13M	﹤0.01%	4139

Other funds holding AMRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Israel Englander's AMRX Position: Q2 2026 in Review

Israel Englander reduced its Amneal Pharmaceuticals (AMRX) stake by 96% in Q2 2026, selling an estimated $4.86M and leaving 14,761 shares worth $256K. The position accounts for ﹤0.01% of the portfolio, ranked #5195.

Israel Englander first reported a position in AMRX in Q2 2018 and has held it in 29 quarters since. The position peaked at $42.3M in Q4 2025. 305 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

Israel Englander held 14,761 shares of Amneal Pharmaceuticals worth $256K as of Q2 2026.
Israel Englander sold 354,972 Amneal Pharmaceuticals shares in Q2 2026, an estimated $4.86M.
Amneal Pharmaceuticals made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #5195 holding.
Israel Englander first reported a position in Amneal Pharmaceuticals in Q2 2018 and has held it in 29 quarters since.
Israel Englander's Amneal Pharmaceuticals position peaked at $42.3M in Q4 2025.
305 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.